FindTrial
Sign In

To assess the effectiveness and safety of dermabrasion followed by tacrolimus and dermabrasion followed by dinoprostone in stable vitiligo patients.

A comparative study to evaluate the efficacy and safety of dinoprostone and tacrolimus following dermabrasion in the treatment of stable vitiligo. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083785
Enrollment
52
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Dermabrasion and 0.1% tacrolimus ointment: One sitting of Dermabrasion followed by application of tacrolimus 0.1% ointment and application of tacrolimus ointment to the dermabraded area

Sponsors

Dr Monika V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to give informed consent. 2.Patient of either gender aged more than 15yrs 3.Patients willing for follow up 4. Patients with clinically diagnosed Stable Vitiligo

Exclusion criteria

Exclusion criteria: 1.Patient not willing to give informed consent 2.Patients having unstable vitiligo 3.Pregnant and lactating females 4.Patients having keloidal tendency 5.Patients having documented hypersensitivity to lignocaine, tacrolimus and dinoprostone.

Design outcomes

Primary

MeasureTime frame
Change in vitiligo area severity index (VASI).Timepoint: Change in vitiligo area severity index (VASI) at: 4,8,12,16,20 and 24 weeks—

Secondary

MeasureTime frame
Safety.Timepoint: Adverse effects at: 4,8,12,16,20 & 24 weeks.—

Countries

India

Contacts

Public ContactDr Shilpa K

Bangalore medical college and research institute

shilpakvinod1980@gmail.com9886553646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026